Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union and European Economic Area

C Ködmön; V Hollo; E Huitric; A Amato-Gauci; D Manissero

doi:10.2807/ese.15.11.19519-en

Rapid communications Open Access

Like 0

Download

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union and European Economic Area
C Ködmön¹ , V Hollo¹ , E Huitric² , A Amato-Gauci³ , D Manissero²
View Affiliations Hide Affiliations

Affiliations: ¹ Surveillance Unit, Tuberculosis Programme, European Centre for Disease Prevention and Control, Stockholm, Sweden ² Scientific Advice Unit, Tuberculosis Programme, European Centre for Disease Prevention and Control, Stockholm, Sweden ³ Surveillance Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden

Correspondence:
C Ködmön
csaba.kodmon ecdc.europa.eu
View Citation Hide Citation

Citation style for this article: Ködmön C, Hollo V, Huitric E, Amato-Gauci A, Manissero D. Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union and European Economic Area. Euro Surveill. 2010;15(11):pii=19519. https://doi.org/10.2807/ese.15.11.19519-en Received: 04 Mar 2010

Abstract

Since 2008, the European Centre for Disease Prevention and Control has been collecting data from the European Union (EU) and European Economic Area (EEA) on resistance to first- and second-line drugs against tuberculosis (TB). In 2008, the proportion of multidrug-resistant tuberculosis (MDR TB) was 6.0% of the total case load for 25 countries reporting data. Extensively drug-resistant (XDR TB) reporting has increased since 2007 and was observed in 7.3% of the MDR TB cases in 13 reporting countries. MDR TB remains a threat and XDR TB is now established within the EU/EEA borders.